<DOC>
	<DOCNO>NCT02235480</DOCNO>
	<brief_summary>The aim study determine efficacy safety topical application gel compare placebo nail psoriasis .</brief_summary>
	<brief_title>Efficacy Safety Tazarotene Gel Nail Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Key inclusion criterion : Mild moderate nail psoriasis least one fingernail Key exclusion criterion : skin condition , potential affect nail interfere evaluation disease ; history hypersensitivity retinoids component trial medication topical treatment nail antipsoriatics 4 week precede treatment phase ; systemic treatment psoriasis within three month treatment phase trial trial intralesional steroid injection treatment phase trial phototherapy treatment phase trial ; chronic infection condition capable interfere conduct trial ; evidence drug alcohol abuse ; symptom clinically significant illness may influence outcome trial four week precede treatment phase trial ; participation another clinical trial within last 4 week prior first treatment clinical trial ; pregnancy nursing ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>